Clinical Trial Update: Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study [NA]

View source ↗

Summary

A multicenter prospective trial evaluating luspatercept for transfusion-dependent non-severe aplastic anemia is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Non-severe Aplastic Anemia

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University | Conditions: Transfusion-dependent Non-severe Aplastic Anemia | NA | Status: NOT_YET_RECRUITING